Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-26-010880
Filing Date
2026-04-01
Accepted
2026-04-01 16:08:21
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A dmtp20260331_defa14a.htm DEFA14A 9847
2 diamedicalogo.jpg GRAPHIC 6910
3 proxy_page1.jpg GRAPHIC 203853
4 proxy_page2.jpg GRAPHIC 156803
  Complete submission text file 0001437749-26-010880.txt   517366
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36291 | Film No.: 26828201
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)